LJP-1586 HCl | CAS#955037-42-0 | 955041-24-4 | VAP-1 inhibitor

MedKoo Cat#: 561435 | Name: LJP-1586 HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LJP-1586 is a highly selective vascular adhesion protein-1 (VAP-1) inhibitor. VAP-1 inhibition provides antiinflammation effect by reducing adhesion molecule expression and immune cell infiltration after intracerebral hemorrhage (ICH).

Chemical Structure

LJP-1586 HCl

CAS#955037-42-0 (HCl)

Theoretical Analysis

MedKoo Cat#: 561435

Name: LJP-1586 HCl

CAS#: 955037-42-0 (HCl)

Chemical Formula: C11H15ClFNO

Exact Mass: 231.0826

Molecular Weight: 231.70

Elemental Analysis: C, 57.02; H, 6.53; Cl, 15.30; F, 8.20; N, 6.05; O, 6.91

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

955037-42-0 (HCl) 955041-24-4 (free base)

Synonym

LJP-1586; LJP1586; LJP 1586; LJP-1586 HCl; LJP-1586 hydrochloride

IUPAC/Chemical Name

(Z)-3-Fluoro-2-(4-methoxybenzyl)allylamine hydrochloride

InChi Key

GNDHRDJFGYCWER-VEZAGKLZSA-N

InChi Code

InChI=1S/C11H14FNO.ClH/c1-14-11-4-2-9(3-5-11)6-10(7-12)8-13;/h2-5,7H,6,8,13H2,1H3;1H/b10-7-;

SMILES Code

NC/C(CC1=CC=C(OC)C=C1)=C\F.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 231.70 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Filip A, Pinzano A, Bianchi A, Fève B, Jalkanen S, Gillet P, Mainard D, Lacolley P, Magdalou J, Mercier N. Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human. Osteoarthritis Cartilage. 2016 Jul;24(7):1223-34. doi: 10.1016/j.joca.2016.01.340. Epub 2016 Feb 4. PubMed PMID: 26851450. 2: Xu H, Testai FD, Valyi-Nagy T, N Pavuluri M, Zhai F, Nanegrungsunk D, Paisansathan C, Pelligrino DA. VAP-1 blockade prevents subarachnoid hemorrhage-associated cerebrovascular dilating dysfunction via repression of a neutrophil recruitment-related mechanism. Brain Res. 2015 Apr 7;1603:141-9. doi: 10.1016/j.brainres.2015.01.047. Epub 2015 Feb 7. PubMed PMID: 25662771. 3: Xu HL, Garcia M, Testai F, Vetri F, Barabanova A, Pelligrino DA, Paisansathan C. Pharmacologic blockade of vascular adhesion protein-1 lessens neurologic dysfunction in rats subjected to subarachnoid hemorrhage. Brain Res. 2014 Oct 24;1586:83-9. doi: 10.1016/j.brainres.2014.08.036. Epub 2014 Aug 29. PubMed PMID: 25175836. 4: Watcharotayangul J, Mao L, Xu H, Vetri F, Baughman VL, Paisansathan C, Pelligrino DA. Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model. J Neurochem. 2012 Nov;123 Suppl 2:116-24. doi: 10.1111/j.1471-4159.2012.07950.x. PubMed PMID: 23050649; PubMed Central PMCID: PMC3481219. 5: Ma Q, Manaenko A, Khatibi NH, Chen W, Zhang JH, Tang J. Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice. J Cereb Blood Flow Metab. 2011 Mar;31(3):881-93. doi: 10.1038/jcbfm.2010.167. Epub 2010 Sep 29. PubMed PMID: 20877383; PubMed Central PMCID: PMC3063621. 6: Marttila-Ichihara F, Castermans K, Auvinen K, Oude Egbrink MG, Jalkanen S, Griffioen AW, Salmi M. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. J Immunol. 2010 Mar 15;184(6):3164-73. doi: 10.4049/jimmunol.0901794. Epub 2010 Feb 12. PubMed PMID: 20154208. 7: O'Rourke AM, Wang EY, Miller A, Podar EM, Scheyhing K, Huang L, Kessler C, Gao H, Ton-Nu HT, Macdonald MT, Jones DS, Linnik MD. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity. J Pharmacol Exp Ther. 2008 Feb;324(2):867-75. Epub 2007 Nov 9. PubMed PMID: 17993604.